Do kappa opioids mimic sigma agonists as amino acid antagonists?

Neuropharmacology. 1986 Feb;25(2):217-20. doi: 10.1016/0028-3908(86)90045-6.

Abstract

The kappa opioids tifluadom and U-50,488 H, when tested on spinal neurones of rats in vivo and frogs in vitro, had no selective effect on responses to microelectrophoretically or bath applied N-methyl-D-aspartate, quisqualate or kainate. In the same preparations ketamine selectively reduces responses to N-methyl-D-aspartate. Amino acid antagonism by dissociative anaesthetics and sigma opioids is thus not mediated by that binding site which kappa and sigma opioids have been reported to have in common.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Amino Acids / antagonists & inhibitors*
  • Analgesics / pharmacology
  • Animals
  • Benzodiazepines / pharmacology
  • Electrophoresis
  • Endorphins / pharmacology*
  • In Vitro Techniques
  • Ketamine / pharmacology
  • Neurotoxins / pharmacology
  • Pyrrolidines / pharmacology
  • Rana pipiens
  • Rana temporaria
  • Rats
  • Receptors, Opioid / physiology*
  • Receptors, Opioid, kappa
  • Receptors, sigma

Substances

  • Amino Acids
  • Analgesics
  • Endorphins
  • Neurotoxins
  • Pyrrolidines
  • Receptors, Opioid
  • Receptors, Opioid, kappa
  • Receptors, sigma
  • Benzodiazepines
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Ketamine
  • tifluadom